Israel Advanced Technology Industries (IATI) has announced details of the upcoming MIXiii Health-Tech.IL conference, taking place at the International Convention Center in Jerusalem on November 9-10, 2022.
The conference will connect Israel’s life sciences industry with major names in international health to explore new developments, the future of health and the shift to a more integrated ecosystem.
Confirmed speakers include executives from leading global corporations including Google, AstraZeneca, Teva and Mayo Clinic, alongside US Ambassador to Israel, Thomas R. Nides.
Karin Mayer Rubinstein, CEO & President Israel Advanced Technology Industries, said:
“We have seen dramatic changes in the health tech industry due to the Covid-19 pandemic, especially through the rapid adoption of digital health and remote health solutions.
Karin Mayer Rubinstein
“We’re excited to host the upcoming MIXiii conference in Jerusalem to showcase these changes and trends and continue to evolve the Israeli life science industry, and its impact on the world.”
The MIXiii Health-Tech.IL Conference will also host a Startup Pavilion led by the Israeli Innovation Authority.
The Pavilion will offer entrepreneurs the opportunity to showcase their innovations to an international audience of decision makers.
Additionally, eHealth Ventures will run a startup competition for digital health companies seeking pre-seed/seed funding.
Israel is a major global health player, with approximately 1,750 life science companies active in the country in 2021, according to AITI research.
View the conference agenda here.
